SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/04/22 Berry Global Group, Inc. 10-Q 7/02/22 62:5.8M Broadridge Fin’l So… Inc |
Document/Exhibit Description Pages Size 1: 10-Q Berry Global Group 10Q HTML 1.19M 2: EX-22.1 Exh 22.1 Subsidiary Guarantors HTML 252K 3: EX-31.1 Exh 31.1 Rule 13A-14(A)/15D-14(A) Certification of HTML 25K the Chief Executive Officer 4: EX-31.2 Exh 31.2 Rule 13A-14(A)/15D-14(A) Certification of HTML 25K the Chief Financial Officer 5: EX-32.1 Exh 32.1 Section 1350 Certification of the Chief HTML 19K Executive Officer 6: EX-32.2 Exh 32.2 Section 1350 Certification of the Chief HTML 19K Financial Officer 12: R1 Document and Entity Information HTML 71K 13: R2 Consolidated Statements of Income HTML 78K 14: R3 Consolidated Statements of Comprehensive Income HTML 45K 15: R4 Consolidated Balance Sheets HTML 129K 16: R5 Consolidated Balance Sheets (Parenthetical) HTML 20K 17: R6 Consolidated Statements of Cash Flows HTML 91K 18: R7 Consolidated Statements of Changes in HTML 64K Stockholders' Equity 19: R8 Basis of Presentation HTML 22K 20: R9 Recent Accounting Pronouncements HTML 31K 21: R10 Revenue and Accounts Receivable HTML 34K 22: R11 Disposition HTML 21K 23: R12 Restructuring and Transaction Activities HTML 50K 24: R13 Leases HTML 43K 25: R14 Long-Term Debt HTML 47K 26: R15 Financial Instruments and Fair Value Measurements HTML 84K 27: R16 Income Taxes HTML 23K 28: R17 Segment and Geographic Data HTML 81K 29: R18 Contingencies and Commitments HTML 21K 30: R19 Share Repurchase Program HTML 24K 31: R20 Basic and Diluted Earnings Per Share HTML 46K 32: R21 Accumulated Other Comprehensive Loss HTML 74K 33: R22 Basis of Presentation (Policies) HTML 29K 34: R23 Recent Accounting Pronouncements (Policies) HTML 21K 35: R24 Restructuring and Transaction Activities (Tables) HTML 52K 36: R25 Leases (Tables) HTML 44K 37: R26 Long-Term Debt (Tables) HTML 46K 38: R27 Financial Instruments and Fair Value Measurements HTML 82K (Tables) 39: R28 Segment and Geographic Data (Tables) HTML 81K 40: R29 Basic and Diluted Earnings Per Share (Tables) HTML 44K 41: R30 Accumulated Other Comprehensive Loss (Tables) HTML 73K 42: R31 Revenue and Accounts Receivable (Details) HTML 23K 43: R32 Disposition (Details) HTML 29K 44: R33 Restructuring and Transaction Activities, HTML 30K Restructuring Charges by Segment (Details) 45: R34 Restructuring and Transaction Activities, HTML 34K Restructuring Accrual Activity (Details) 46: R35 Leases (Details) HTML 61K 47: R36 Long-Term Debt (Details) HTML 68K 48: R37 Financial Instruments and Fair Value Measurements, HTML 34K Cross-Currency Swaps (Details) 49: R38 Financial Instruments and Fair Value Measurements, HTML 41K Interest Rate Swaps (Details) 50: R39 Financial Instruments and Fair Value Measurements, HTML 33K Fair Value of Derivative and Location on Consolidated Balance Sheets (Details) 51: R40 Financial Instruments and Fair Value Measurements, HTML 25K Effect of Derivatives on Consolidated Statements of Income (Details) 52: R41 Financial Instruments and Fair Value Measurements, HTML 59K Assets Measured at Fair Value on Non-Recurring Basis (Details) 53: R42 Segment and Geographic Data, Selected Information HTML 47K by Reportable Segment (Details) 54: R43 Segment and Geographic Data, Selected Information HTML 32K by Geographical Region (Details) 55: R44 Share Repurchase Program (Details) HTML 28K 56: R45 Basic and Diluted Earnings Per Share (Details) HTML 58K 57: R46 Accumulated Other Comprehensive Loss (Details) HTML 41K 60: XML IDEA XML File -- Filing Summary XML 106K 58: XML XBRL Instance -- form10q_htm XML 1.46M 59: EXCEL IDEA Workbook of Financial Reports XLSX 82K 8: EX-101.CAL XBRL Calculations -- bery-20220702_cal XML 130K 9: EX-101.DEF XBRL Definitions -- bery-20220702_def XML 336K 10: EX-101.LAB XBRL Labels -- bery-20220702_lab XML 1.15M 11: EX-101.PRE XBRL Presentations -- bery-20220702_pre XML 622K 7: EX-101.SCH XBRL Schema -- bery-20220702 XSD 101K 61: JSON XBRL Instance as JSON Data -- MetaLinks 284± 414K 62: ZIP XBRL Zipped Folder -- 0001140361-22-028207-xbrl Zip 235K
i ☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
i ☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF 1934
|
A i Delaware corporation
|
i 101 Oakley Street, i Evansville, i Indiana,
i 47710
( i 812) i 424-2904
|
IRS employer identification number
i 20-5234618
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
i Common Stock, $0.01 par value per share
|
i BERY
|
i New York Stock Exchange LLC
|
i Large Accelerated Filer ☒
|
Accelerated Filer ☐
|
Non-Accelerated Filer ☐
|
Smaller Reporting Company i ☐
|
Emerging Growth Company i ☐
|
Part I.
|
Financial Information
|
Page No.
|
|
Item 1.
|
Financial Statements:
|
||
4
|
|||
5
|
|||
6
|
|||
7
|
|||
8
|
|||
Item 2.
|
14
|
||
Item 3.
|
21
|
||
Item 4.
|
21
|
||
Part II.
|
Other Information
|
||
Item 1.
|
22
|
||
Item 1A.
|
22
|
||
Item 2.
|
22
|
||
Item 6.
|
23
|
||
24
|
Item 1. |
Financial Statements
|
Quarterly Period Ended
|
Three Quarterly Periods Ended
|
|||||||||||||||
Net sales
|
$
|
i 3,726
|
$
|
i 3,675
|
$
|
i 11,074
|
$
|
i 10,181
|
||||||||
Costs and expenses:
|
||||||||||||||||
Cost of goods sold
|
i 3,105
|
i 3,049
|
i 9,297
|
i 8,273
|
||||||||||||
Selling, general and administrative
|
i 215
|
i 207
|
i 657
|
i 668
|
||||||||||||
Amortization of intangibles
|
i 63
|
i 72
|
i 196
|
i 219
|
||||||||||||
Restructuring and transaction activities
|
i 7
|
i 4
|
i 18
|
i 41
|
||||||||||||
Operating income
|
i 336
|
i 343
|
i 906
|
i 980
|
||||||||||||
Other expense
|
i 7
|
i 14
|
i 13
|
i 45
|
||||||||||||
Interest expense
|
i 70
|
i 76
|
i 212
|
i 257
|
||||||||||||
Income before income taxes
|
i 259
|
i 253
|
i 681
|
i 678
|
||||||||||||
Income tax expense
|
i 52
|
i 59
|
i 148
|
i 173
|
||||||||||||
Net income
|
$
|
i 207
|
$
|
i 194
|
$
|
i 533
|
$
|
i 505
|
||||||||
Net income per share:
|
||||||||||||||||
Basic
|
$
|
i 1.61
|
$
|
i 1.44
|
$
|
i 4.02
|
$
|
i 3.76
|
||||||||
Diluted
|
i 1.58
|
i 1.40
|
i 3.93
|
i 3.67
|
Quarterly Period Ended
|
Three Quarterly Periods Ended
|
|||||||||||||||
Net income
|
$
|
i 207
|
$
|
i 194
|
$
|
i 533
|
$
|
i 505
|
||||||||
Other comprehensive income, net of tax:
|
||||||||||||||||
Currency translation
|
( i 159
|
)
|
i 91
|
( i 144
|
)
|
i 196
|
||||||||||
Derivative instruments
|
i 19
|
( i 2
|
)
|
i 119
|
i 69
|
|||||||||||
Other comprehensive (loss) income
|
( i 140
|
)
|
i 89
|
( i 25
|
)
|
i 265
|
||||||||||
Comprehensive income
|
$
|
i 67
|
$
|
i 283
|
$
|
i 508
|
$
|
i 770
|
(Unaudited)
|
||||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
i 527
|
$
|
i 1,091
|
||||
Accounts receivable
|
i 1,974
|
i 1,879
|
||||||
Finished goods
|
i 1,027
|
i 960
|
||||||
Raw materials and supplies
|
i 951
|
i 947
|
||||||
Prepaid expenses and other current assets
|
i 237
|
i 217
|
||||||
Total current assets
|
i 4,716
|
i 5,094
|
||||||
Noncurrent assets:
|
||||||||
Property, plant and equipment
|
i 4,560
|
i 4,677
|
||||||
Goodwill and intangible assets
|
i 6,942
|
i 7,434
|
||||||
Right-of-use assets
|
i 522
|
i 562
|
||||||
Other assets
|
i 145
|
i 115
|
||||||
Total assets
|
$
|
i 16,885
|
$
|
i 17,882
|
||||
Liabilities and stockholders’ equity
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
i 1,518
|
$
|
i 2,041
|
||||
Accrued employee costs
|
i 260
|
i 336
|
||||||
Other current liabilities
|
i 837
|
i 788
|
||||||
Current portion of long-term debt
|
i 15
|
i 21
|
||||||
Total current liabilities
|
i 2,630
|
i 3,186
|
||||||
Noncurrent liabilities:
|
||||||||
Long-term debt
|
i 9,488
|
i 9,439
|
||||||
Deferred income taxes
|
i 606
|
i 568
|
||||||
Employee benefit obligations
|
i 223
|
i 276
|
||||||
Operating lease liabilities
|
i 432
|
i 466
|
||||||
Other long-term liabilities
|
i 397
|
i 767
|
||||||
Total liabilities
|
i 13,776
|
i 14,702
|
||||||
Stockholders’ equity:
|
||||||||
Common stock ( i 125.4 and i 135.5 million shares issued, respectively)
|
i 1
|
i 1
|
||||||
Additional paid-in capital
|
i 1,171
|
i 1,134
|
||||||
Retained earnings
|
i 2,258
|
i 2,341
|
||||||
Accumulated other comprehensive loss
|
( i 321
|
)
|
( i 296
|
)
|
||||
Total stockholders’ equity
|
i 3,109
|
i 3,180
|
||||||
Total liabilities and stockholders’ equity
|
$
|
i 16,885
|
$
|
i 17,882
|
Three Quarterly Periods Ended
|
||||||||
Cash Flows from Operating Activities:
|
||||||||
Net income
|
$
|
i 533
|
$
|
i 505
|
||||
Adjustments to reconcile net cash from operating activities:
|
||||||||
Depreciation
|
i 424
|
i 420
|
||||||
Amortization of intangibles
|
i 196
|
i 219
|
||||||
Non-cash interest expense
|
i 11
|
i 26
|
||||||
Deferred income tax
|
( i 66
|
)
|
( i 53
|
)
|
||||
Share-based compensation expense
|
i 34
|
i 34
|
||||||
Other non-cash operating activities, net
|
( i 2
|
)
|
i 60
|
|||||
Settlement of derivatives
|
i 69
|
i —
|
||||||
Changes in working capital
|
( i 800
|
)
|
( i 278
|
)
|
||||
Changes in other assets and liabilities
|
( i 54
|
)
|
( i 21
|
)
|
||||
Net cash from operating activities
|
i 345
|
i 912
|
||||||
Cash Flows from Investing Activities:
|
||||||||
Additions to property, plant and equipment, net
|
( i 556
|
)
|
( i 520
|
)
|
||||
Divestiture of businesses
|
i 125
|
i 165
|
||||||
Other investing activities
|
i 6
|
i —
|
||||||
Net cash from investing activities
|
( i 425
|
)
|
( i 355
|
)
|
||||
Cash Flows from Financing Activities:
|
||||||||
Proceeds from long-term borrowings
|
i 170
|
i 2,716
|
||||||
Repayments on long-term borrowings
|
( i 16
|
)
|
( i 3,287
|
)
|
||||
Proceeds from issuance of common stock
|
i 24
|
i 57
|
||||||
Repurchase of common stock
|
( i 637
|
)
|
i —
|
|||||
Debt financing costs
|
i —
|
( i 20
|
)
|
|||||
Net cash from financing activities
|
( i 459
|
)
|
( i 534
|
)
|
||||
Effect of currency translation on cash
|
( i 25
|
)
|
i 31
|
|||||
Net change in cash and cash equivalents
|
( i 564
|
)
|
i 54
|
|||||
Cash and cash equivalents at beginning of period
|
i 1,091
|
i 750
|
||||||
Cash and cash equivalents at end of period
|
$
|
i 527
|
$
|
i 804
|
Quarterly Period Ended
|
Common
Stock
|
Additional
Paid-in Capital
|
Accumulated Other
Comprehensive Loss
|
Retained
Earnings
|
Total
|
|||||||||||||||
Balance at April 2, 2022
|
$
|
i 1
|
$
|
i 1,174
|
$
|
( i 181
|
)
|
$
|
i 2,326
|
$
|
i 3,320
|
|||||||||
Net income
|
i —
|
i —
|
i —
|
i 207
|
i 207
|
|||||||||||||||
Other comprehensive income
|
i —
|
i —
|
( i 140
|
)
|
i —
|
( i 140
|
)
|
|||||||||||||
Share-based compensation
|
i —
|
i 6
|
i —
|
i —
|
i 6
|
|||||||||||||||
Proceeds from issuance of common stock
|
i —
|
i 2
|
i —
|
i —
|
i 2
|
|||||||||||||||
Common stock repurchased and retired
|
i —
|
( i 11
|
)
|
i —
|
( i 275
|
)
|
( i 286
|
)
|
||||||||||||
Balance at July 2, 2022
|
$
|
i 1
|
$
|
i 1,171
|
$
|
( i 321
|
)
|
$
|
i 2,258
|
$
|
i 3,109
|
|||||||||
Balance at April 3, 2021
|
$
|
i 1
|
$
|
i 1,101
|
$
|
( i 375
|
)
|
$
|
i 1,919
|
$
|
i 2,646
|
|||||||||
Net income
|
i —
|
i —
|
i —
|
i 194
|
i 194
|
|||||||||||||||
Other comprehensive loss
|
i —
|
i —
|
i 89
|
i —
|
i 89
|
|||||||||||||||
Share-based compensation
|
i —
|
i 6
|
i —
|
i —
|
i 6
|
|||||||||||||||
Proceeds from issuance of common stock
|
i —
|
i 18
|
i —
|
i —
|
i 18
|
|||||||||||||||
Balance at July 3, 2021
|
$
|
i 1
|
$
|
i 1,125
|
$
|
( i 286
|
)
|
$
|
i 2,113
|
$
|
i 2,953
|
Three Quarterly Periods Ended
|
Common
Stock
|
Additional
Paid-in Capital
|
Accumulated Other
Comprehensive Loss
|
Retained
Earnings
|
Total
|
|||||||||||||||
Balance at October 2, 2021
|
$
|
i 1
|
$
|
i 1,134
|
$
|
( i 296
|
)
|
$
|
i 2,341
|
$
|
i 3,180
|
|||||||||
Net income
|
i —
|
i —
|
i —
|
i 533
|
i 533
|
|||||||||||||||
Other comprehensive income
|
i —
|
i —
|
( i 25
|
)
|
i —
|
( i 25
|
)
|
|||||||||||||
Share-based compensation
|
i —
|
i 34
|
i —
|
i —
|
i 34
|
|||||||||||||||
Proceeds from issuance of common stock
|
i —
|
i 24
|
i —
|
i —
|
i 24
|
|||||||||||||||
Common stock repurchased and retired
|
i —
|
( i 21
|
)
|
i —
|
( i 616
|
)
|
( i 637
|
)
|
||||||||||||
Balance at July 2, 2022
|
$
|
i 1
|
$
|
i 1,171
|
$
|
( i 321
|
)
|
$
|
i 2,258
|
$
|
i 3,109
|
|||||||||
Balance at September 26, 2020
|
$
|
i 1
|
$
|
i 1,034
|
$
|
( i 551
|
)
|
$
|
i 1,608
|
$
|
i 2,092
|
|||||||||
Net income
|
i —
|
i —
|
i —
|
i 505
|
i 505
|
|||||||||||||||
Other comprehensive income
|
i —
|
i —
|
i 265
|
i —
|
i 265
|
|||||||||||||||
Share-based compensation
|
i —
|
i 34
|
i —
|
i —
|
i 34
|
|||||||||||||||
Proceeds from issuance of common stock
|
i —
|
i 57
|
i —
|
i —
|
i 57
|
|||||||||||||||
Balance at July 3, 2021
|
$
|
i 1
|
$
|
i 1,125
|
$
|
( i 286
|
)
|
$
|
i 2,113
|
$
|
i 2,953
|
Quarterly Period Ended
|
Three Quarterly Periods Ended
|
|||||||||||||||
Consumer Packaging International
|
$
|
i 3
|
$
|
i 3
|
$
|
i 10
|
$
|
i 44
|
||||||||
Consumer Packaging North America
|
i 1
|
i —
|
i 4
|
i 1
|
||||||||||||
Health, Hygiene & Specialties
|
i 3
|
i —
|
i 2
|
i —
|
||||||||||||
Engineered Materials
|
i —
|
i 1
|
i 2
|
( i 4
|
)
|
|||||||||||
Consolidated
|
$
|
i 7
|
$
|
i 4
|
$
|
i 18
|
$
|
i 41
|
Restructuring
|
||||||||||||||||
Employee Severance
and Benefits
|
Facility
Exit Costs
|
Transaction
Activities
|
Total
|
|||||||||||||
Balance as of October 2, 2021
|
$
|
i 6
|
$
|
i 5
|
$
|
i —
|
$
|
i 11
|
||||||||
Charges
|
i 4
|
i 7
|
i 7
|
i 18
|
||||||||||||
Cash
|
( i 6
|
)
|
( i 9
|
)
|
( i 7
|
)
|
( i 22
|
)
|
||||||||
Balance as of July 2, 2022
|
$
|
i 4
|
$
|
i 3
|
$
|
i —
|
$
|
i 7
|
Leases
|
Classification
|
||||||||
Operating leases:
|
|||||||||
Operating lease right-of-use assets
|
Right-of-use assets
|
$
|
i 522
|
$
|
i 562
|
||||
Current operating lease liabilities
|
Other current liabilities
|
i 107
|
i 113
|
||||||
Noncurrent operating lease liabilities
|
Operating lease liability
|
i 432
|
i 466
|
||||||
Finance leases:
|
|||||||||
Finance lease right-of-use assets
|
Property, plant, and equipment, net
|
$
|
i 40
|
$
|
i 57
|
||||
Current finance lease liability
|
Current portion of long-term debt
|
i 10
|
i 14
|
||||||
Noncurrent finance lease liabilities
|
Long-term debt, less current portion
|
i 27
|
i 38
|
Three Quarterly Periods Ended
|
||||||||||||
Lease Type
|
Cash Flow Classification
|
Lease Expense Category
|
||||||||||
Operating
|
Operating
|
Lease cost
|
$
|
i 100
|
$
|
i 85
|
||||||
Finance
|
Operating
|
Interest expense
|
i 1
|
i 2
|
||||||||
Finance
|
Financing
|
- |
i 14
|
i 19
|
||||||||
Finance
|
-
|
Amortization of right-of-use assets
|
i 7
|
i 9
|
Facility
|
Maturity Date
|
||||||||
Term loan
|
July 2026
|
$
|
i 3,440
|
i 3,440
|
|||||
Revolving line of credit
|
May 2024
|
i 170
|
i —
|
||||||
i 0.95%
First Priority Senior Secured Notes
|
February 2024
|
i 800
|
i 800
|
||||||
i 1.00%
First Priority Senior Secured Notes (a)
|
July 2025
|
i 734
|
i 810
|
||||||
i 1.57%
First Priority Senior Secured Notes
|
January 2026
|
i 1,525
|
i 1,525
|
||||||
i 4.875%
First Priority Senior Secured Notes
|
July 2026
|
i 1,250
|
i 1,250
|
||||||
i 1.65%
First Priority Senior Secured Notes
|
January 2027
|
i 400
|
i 400
|
||||||
i 1.50%
First Priority Senior Secured Notes (a)
|
July 2027
|
i 393
|
i 434
|
||||||
i 4.50%
Second Priority Senior Secured Notes
|
February 2026
|
i 300
|
i 300
|
||||||
i 5.625%
Second Priority Senior Secured Notes
|
July 2027
|
i 500
|
i 500
|
||||||
Debt discounts and deferred fees
|
( i 65
|
)
|
( i 77
|
)
|
|||||
Finance leases and other
|
Various
|
i 56
|
i 78
|
||||||
Total long-term debt
|
i 9,503
|
i 9,460
|
|||||||
Current portion of long-term debt
|
( i 15
|
)
|
( i 21
|
)
|
|||||
Long-term debt, less current portion
|
$
|
i 9,488
|
i 9,439
|
(a) |
Euro denominated
|
Derivative Instruments
|
Hedge Designation
|
Balance Sheet Location
|
||||||||
Cross-currency swaps
|
Designated
|
Other assets
|
$
|
i 18
|
$
|
i —
|
||||
Cross-currency swaps
|
Designated
|
Other long-term liabilities
|
i 40
|
i 323
|
||||||
Interest rate swaps
|
Designated
|
Other assets
|
i 34
|
i —
|
||||||
Interest rate swaps
|
Designated
|
Other long-term liabilities
|
i —
|
i 82
|
||||||
Interest rate swaps
|
Not designated
|
Other assets
|
i 7
|
i —
|
||||||
Interest rate swaps
|
Not designated
|
Other long-term liabilities
|
i 81
|
i 49
|
Quarterly Period Ended
|
Three Quarterly Periods Ended
|
||||||||||||||||
Derivative Instruments
|
Statements of Income Location
|
||||||||||||||||
Cross-currency swaps
|
Interest expense
|
$
|
( i 5
|
)
|
$
|
( i 2
|
)
|
$
|
( i 12
|
)
|
$
|
( i 6
|
)
|
||||
Interest rate swaps
|
Interest expense
|
i 11
|
i 18
|
i 35
|
i 52
|
As of July 2, 2022
|
||||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
Impairment
|
||||||||||||||||
Indefinite-lived trademarks
|
$
|
i —
|
$
|
i —
|
$
|
i 248
|
$
|
i 248
|
$
|
i —
|
||||||||||
Goodwill
|
i —
|
i —
|
i 4,969
|
i 4,969
|
i —
|
|||||||||||||||
Definite lived intangible assets
|
i —
|
i —
|
i 1,725
|
i 1,725
|
i —
|
|||||||||||||||
Property, plant, and equipment
|
i —
|
i —
|
i 4,560
|
i 4,560
|
i —
|
|||||||||||||||
Total
|
$
|
i —
|
$
|
i —
|
$
|
i 11,502
|
$
|
i 11,502
|
$
|
i —
|
As of October 2, 2021
|
||||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
Impairment
|
||||||||||||||||
Indefinite-lived trademarks
|
$
|
i —
|
$
|
i —
|
$
|
i 248
|
$
|
i 248
|
$
|
i —
|
||||||||||
Goodwill
|
i —
|
i —
|
i 5,192
|
i 5,192
|
i —
|
|||||||||||||||
Definite lived intangible assets
|
i —
|
i —
|
i 1,994
|
i 1,994
|
i —
|
|||||||||||||||
Property, plant, and equipment
|
i —
|
i —
|
i 4,677
|
i 4,677
|
i 1
|
|||||||||||||||
Total
|
$
|
i —
|
$
|
i —
|
$
|
i 12,111
|
$
|
i 12,111
|
$
|
i 1
|
Quarterly Period Ended
|
Three Quarterly Periods Ended
|
|||||||||||||||
Net sales:
|
||||||||||||||||
Consumer Packaging International
|
$
|
i 1,096
|
$
|
i 1,095
|
$
|
i 3,290
|
$
|
i 3,143
|
||||||||
Consumer Packaging North America
|
i 927
|
i 847
|
i 2,659
|
i 2,264
|
||||||||||||
Health, Hygiene & Specialties
|
i 788
|
i 828
|
i 2,429
|
i 2,349
|
||||||||||||
Engineered Materials
|
i 915
|
i 905
|
i 2,696
|
i 2,425
|
||||||||||||
Total net sales
|
$
|
i 3,726
|
$
|
i 3,675
|
$
|
i 11,074
|
$
|
i 10,181
|
||||||||
Operating income:
|
||||||||||||||||
Consumer Packaging International
|
$
|
i 82
|
$
|
i 79
|
$
|
i 248
|
$
|
i 214
|
||||||||
Consumer Packaging North America
|
i 104
|
i 76
|
i 235
|
i 212
|
||||||||||||
Health, Hygiene & Specialties
|
i 56
|
i 113
|
i 186
|
i 323
|
||||||||||||
Engineered Materials
|
i 94
|
i 75
|
i 237
|
i 231
|
||||||||||||
Total operating income
|
$
|
i 336
|
$
|
i 343
|
$
|
i 906
|
$
|
i 980
|
||||||||
Depreciation and amortization:
|
||||||||||||||||
Consumer Packaging International
|
$
|
i 78
|
$
|
i 88
|
$
|
i 242
|
$
|
i 258
|
||||||||
Consumer Packaging North America
|
i 53
|
i 53
|
i 160
|
i 164
|
||||||||||||
Health, Hygiene & Specialties
|
i 44
|
i 43
|
i 133
|
i 130
|
||||||||||||
Engineered Materials
|
i 28
|
i 28
|
i 85
|
i 87
|
||||||||||||
Total depreciation and amortization
|
$
|
i 203
|
$
|
i 212
|
$
|
i 620
|
$
|
i 639
|
Quarterly Period Ended
|
Three Quarterly Periods Ended
|
|||||||||||||||
Net sales:
|
||||||||||||||||
United States and Canada
|
$
|
i 2,030
|
$
|
i 1,937
|
$
|
i 5,978
|
$
|
i 5,342
|
||||||||
Europe
|
i 1,320
|
i 1,308
|
i 3,937
|
i 3,658
|
||||||||||||
Rest of world
|
i 376
|
i 430
|
i 1,160
|
i 1,181
|
||||||||||||
Total net sales
|
$
|
i 3,726
|
$
|
i 3,675
|
$
|
i 11,074
|
$
|
i 10,181
|
Quarterly Period Ended
|
Three Quarterly Periods Ended
|
|||||||||||||||
(in millions, except per share amounts)
|
||||||||||||||||
Numerator
|
||||||||||||||||
Consolidated net income
|
$
|
i 207
|
$
|
i 194
|
$
|
i 533
|
$
|
i 505
|
||||||||
Denominator
|
||||||||||||||||
Weighted average common shares outstanding - basic
|
i 128.6
|
i 135.1
|
i 132.6
|
i 134.3
|
||||||||||||
Dilutive shares
|
i 2.1
|
i 3.4
|
i 3.0
|
i 3.4
|
||||||||||||
Weighted average common and common equivalent shares outstanding - diluted
|
i 130.7
|
i 138.5
|
i 135.6
|
i 137.7
|
||||||||||||
Per common share earnings
|
||||||||||||||||
Basic
|
$
|
i 1.61
|
$
|
i 1.44
|
$
|
i 4.02
|
$
|
i 3.76
|
||||||||
Diluted
|
$
|
i 1.58
|
$
|
i 1.40
|
$
|
i 3.93
|
$
|
i 3.67
|
Quarterly Period Ended
|
Currency
Translation
|
Defined Benefit
Pension and Retiree
Health Benefit Plans
|
Derivative
Instruments
|
Accumulated Other
Comprehensive Loss
|
||||||||||||
Balance at April 2, 2022
|
$
|
( i 139
|
)
|
$
|
( i 67
|
)
|
$
|
i 25
|
$
|
( i 181
|
)
|
|||||
Other comprehensive income (loss) before reclassifications
|
( i 159
|
)
|
i —
|
i 18
|
( i 141
|
)
|
||||||||||
Net amount reclassified
|
i —
|
i —
|
i 1
|
i 1
|
||||||||||||
Balance at July 2, 2022
|
$
|
( i 298
|
)
|
$
|
( i 67
|
)
|
$
|
i 44
|
$
|
( i 321
|
)
|
Currency
Translation
|
Defined Benefit
Pension and Retiree
Health Benefit Plans
|
Derivative
Instruments
|
Accumulated Other
Comprehensive Loss
|
|||||||||||||
Balance at April 3, 2021
|
$
|
( i 173
|
)
|
$
|
( i 116
|
)
|
$
|
( i 86
|
)
|
$
|
( i 375
|
)
|
||||
Other comprehensive income (loss) before reclassifications
|
i 91
|
i —
|
( i 5
|
)
|
i 86
|
|||||||||||
Net amount reclassified
|
i —
|
i —
|
i 3
|
i 3
|
||||||||||||
Balance at July 3, 2021
|
$
|
( i 82
|
)
|
$
|
( i 116
|
)
|
$
|
( i 88
|
)
|
$
|
( i 286
|
)
|
Three Quarterly Periods Ended
|
Currency
Translation
|
Defined Benefit
Pension and Retiree
Health Benefit Plans
|
Derivative
Instruments
|
Accumulated Other
Comprehensive Loss
|
||||||||||||
Balance at October 2, 2021
|
$
|
( i 154
|
)
|
$
|
( i 67
|
)
|
$
|
( i 75
|
)
|
$
|
( i 296
|
)
|
||||
Other comprehensive income (loss) before reclassifications
|
( i 144
|
)
|
i —
|
i 113
|
( i 31
|
)
|
||||||||||
Net amount reclassified
|
i —
|
i —
|
i 6
|
i 6
|
||||||||||||
Balance at July 2, 2022
|
$
|
( i 298
|
)
|
$
|
( i 67
|
)
|
$
|
i 44
|
$
|
( i 321
|
)
|
Currency
Translation
|
Defined Benefit
Pension and Retiree
Health Benefit Plans
|
Derivative
Instruments
|
Accumulated Other
Comprehensive Loss
|
|||||||||||||
Balance at September 26, 2020
|
$
|
( i 278
|
)
|
$
|
( i 116
|
)
|
$
|
( i 157
|
)
|
$
|
( i 551
|
)
|
||||
Other comprehensive income before reclassifications
|
i 196
|
i —
|
i 62
|
i 258
|
||||||||||||
Net amount reclassified
|
i —
|
i —
|
i 7
|
i 7
|
||||||||||||
Balance at July 3, 2021
|
$
|
( i 82
|
)
|
$
|
( i 116
|
)
|
$
|
( i 88
|
)
|
$
|
( i 286
|
)
|
Consolidated Overview
|
||||||||||||||||
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
3,726
|
$
|
3,675
|
$
|
51
|
1
|
%
|
||||||||
Cost of goods sold
|
3,105
|
3,049
|
56
|
2
|
%
|
|||||||||||
Other operating expenses
|
285
|
283
|
2
|
1
|
%
|
|||||||||||
Operating income
|
$
|
336
|
$
|
343
|
$
|
(7
|
)
|
(2
|
)%
|
Consumer Packaging International
|
||||||||||||||||
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
1,096
|
$
|
1,095
|
$
|
1
|
—
|
|||||||||
Operating income
|
$
|
82
|
$
|
79
|
$
|
3
|
4
|
%
|
Consumer Packaging North America
|
||||||||||||||||
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
927
|
$
|
847
|
$
|
80
|
9
|
%
|
||||||||
Operating income
|
$
|
104
|
$
|
76
|
$
|
28
|
37
|
%
|
Health, Hygiene & Specialties
|
||||||||||||||||
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
788
|
$
|
828
|
$
|
(40
|
)
|
(5
|
)%
|
|||||||
Operating income
|
$
|
56
|
$
|
113
|
$
|
(57
|
)
|
(50
|
)%
|
Engineered Materials
|
||||||||||||||||
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
915
|
$
|
905
|
$
|
10
|
1
|
%
|
||||||||
Operating income
|
$
|
94
|
$
|
75
|
$
|
19
|
25
|
%
|
Other expense, net
|
||||||||||||||||
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
Other expense, net
|
$
|
7
|
$
|
14
|
$
|
(7
|
)
|
(50
|
)%
|
Interest expense, net
|
||||||||||||||||
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
Interest expense, net
|
$
|
70
|
$
|
76
|
$
|
(6
|
)
|
(8
|
)%
|
Consolidated Overview
|
||||||||||||||||
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
11,074
|
$
|
10,181
|
$
|
893
|
9
|
%
|
||||||||
Cost of goods sold
|
9,297
|
8,273
|
1,024
|
12
|
%
|
|||||||||||
Other operating expenses
|
871
|
928
|
(57
|
)
|
(6
|
)%
|
||||||||||
Operating income
|
$
|
906
|
$
|
980
|
$
|
(74
|
)
|
(8
|
)%
|
Consumer Packaging International
|
||||||||||||||||
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
3,290
|
$
|
3,143
|
$
|
147
|
5
|
%
|
||||||||
Operating income
|
$
|
248
|
$
|
214
|
$
|
34
|
16
|
%
|
Consumer Packaging North America
|
||||||||||||||||
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
2,659
|
$
|
2,264
|
$
|
395
|
17
|
%
|
||||||||
Operating income
|
$
|
235
|
$
|
212
|
$
|
23
|
11
|
%
|
Health, Hygiene & Specialties
|
||||||||||||||||
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
2,429
|
$
|
2,349
|
$
|
80
|
3
|
%
|
||||||||
Operating income
|
$
|
186
|
$
|
323
|
$
|
(137
|
)
|
(42
|
)%
|
Engineered Materials
|
||||||||||||||||
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
2,696
|
$
|
2,425
|
$
|
271
|
11
|
%
|
||||||||
Operating income
|
$
|
237
|
$
|
231
|
$
|
6
|
3
|
%
|
Other expense
|
||||||||||||||||
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
Other expense
|
$
|
13
|
$
|
45
|
$
|
(32
|
)
|
(71
|
)%
|
Interest expense
|
||||||||||||||||
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
Interest expense
|
$
|
212
|
$
|
257
|
$
|
(45
|
)
|
(18
|
)%
|
Fiscal 2022 Outlook
|
||||||||
Cash flow from operating activities
|
$
|
345
|
$
|
1,500
|
||||
Additions to property, plant and equipment, net
|
(556
|
)
|
(750
|
)
|
||||
Free cash flow
|
$
|
(211
|
)
|
$
|
750
|
Three Quarterly Periods Ended
|
||||
Net sales
|
$
|
5,772
|
||
Gross profit
|
956
|
|||
Earnings from continuing operations
|
319
|
|||
Net income
|
$
|
319
|
Assets
|
||||||||
Current assets
|
$
|
2,008
|
$
|
2,293
|
||||
Noncurrent assets
|
6,040
|
5,979
|
||||||
Liabilities
|
||||||||
Current liabilities
|
$
|
1,225
|
$
|
1,533
|
||||
Intercompany payable
|
634
|
629
|
||||||
Noncurrent liabilities
|
10,812
|
11,083
|
Fiscal Period
|
Total Number of
Shares Purchased
|
Average Price
Paid Per Share
|
Total Number of Shares
Purchased as Part of Publicly
Announced Programs
|
Dollar Value of Shares that
May Yet be Purchased Under
the Program (in millions) (a)
|
||||||||||||
April
|
147,000
|
$
|
59.03
|
147,000
|
$
|
691
|
||||||||||
May
|
2,912,000
|
55.93
|
2,912,000
|
528
|
||||||||||||
June
|
2,055,150
|
55.51
|
2,055,150
|
414
|
||||||||||||
Total
|
5,114,150
|
$
|
55.85
|
5,114,150
|
$
|
414
|
(a) |
All open market purchases during the quarter were made under the fiscal 2022 authorization from our board of directors to
purchase up to $1 billion of shares of common stock. (See Note 12.)
|
Exhibit No.
|
Description of Exhibit
|
|
22.1*
|
Subsidiary Guarantors
|
|
31.1*
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
|
|
31.2*
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
|
|
32.1**
|
Section 1350 Certification of the Chief Executive Officer.
|
|
32.2**
|
Section 1350 Certification of the Chief Financial Officer.
|
|
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline
XBRL document).
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
104
|
Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101).
|
* |
** |
Furnished herewith
|
Berry Global Group, Inc.
|
|||
By:
|
/s/ Mark W. Miles
|
||
Chief Financial Officer
|
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/4/22 | |||
For Period end: | 7/2/22 | |||
4/2/22 | 10-Q | |||
2/24/22 | ||||
10/2/21 | 10-K | |||
7/3/21 | 10-Q | |||
4/3/21 | 10-Q | |||
9/26/20 | 10-K, 8-K | |||
List all Filings |